Pharma Aids Limited (DSE: PHARMAID)
Bangladesh
· Delayed Price · Currency is BDT
720.20
+15.20 (2.16%)
At close: Sep 12, 2024
Pharma Aids Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
Cash & Equivalents | 50.15 | 15.12 | 24.91 | 19.98 | 14.08 | 9.78 | Upgrade
|
Cash & Short-Term Investments | 50.15 | 15.12 | 24.91 | 19.98 | 14.08 | 9.78 | Upgrade
|
Cash Growth | 85.49% | -39.30% | 24.68% | 41.86% | 43.93% | 71.59% | Upgrade
|
Accounts Receivable | 150.38 | 127.1 | 123.51 | 127.23 | 136.39 | 105.12 | Upgrade
|
Other Receivables | 27.87 | 28.06 | 29.31 | 32.16 | 39.46 | 28.67 | Upgrade
|
Receivables | 178.25 | 155.16 | 152.82 | 159.4 | 175.85 | 133.79 | Upgrade
|
Inventory | 56.09 | 56.83 | 63.67 | 39.36 | 24.45 | 39.18 | Upgrade
|
Prepaid Expenses | 28.01 | 21.5 | 14.53 | 7.9 | 5.44 | - | Upgrade
|
Other Current Assets | 82.21 | 65.87 | 51.62 | 40.62 | 21.4 | 24.67 | Upgrade
|
Total Current Assets | 394.72 | 314.48 | 307.54 | 267.25 | 241.22 | 207.43 | Upgrade
|
Property, Plant & Equipment | 61.78 | 66.86 | 72.27 | 75.4 | 74.12 | 78.83 | Upgrade
|
Total Assets | 456.5 | 381.34 | 379.82 | 342.65 | 315.34 | 286.26 | Upgrade
|
Accounts Payable | 4.47 | 1.66 | 1.42 | 0.16 | 0.43 | 1.23 | Upgrade
|
Accrued Expenses | 39.94 | 29.72 | 32.13 | 23.69 | 23.35 | 17.37 | Upgrade
|
Short-Term Debt | 3.87 | 11.47 | 0.99 | 0.3 | 5.09 | 14.97 | Upgrade
|
Current Income Taxes Payable | 66.93 | 50.05 | 33.32 | 14.83 | 17.6 | 16.4 | Upgrade
|
Other Current Liabilities | 2.19 | 3.44 | 3.34 | 12.68 | 11.32 | 14.53 | Upgrade
|
Total Current Liabilities | 117.39 | 96.34 | 71.2 | 51.67 | 57.79 | 64.49 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.14 | 0.22 | 0.27 | - | - | - | Upgrade
|
Total Liabilities | 117.53 | 96.56 | 71.47 | 51.67 | 57.79 | 64.49 | Upgrade
|
Common Stock | 31.2 | 31.2 | 31.2 | 31.2 | 31.2 | 31.2 | Upgrade
|
Retained Earnings | 306.61 | 253.58 | 275.56 | 257.09 | 223.43 | 187.87 | Upgrade
|
Comprensive Income & Other | 1.15 | 0 | 1.59 | 2.69 | 2.92 | 2.7 | Upgrade
|
Shareholders' Equity | 338.96 | 284.78 | 308.35 | 290.98 | 257.56 | 221.78 | Upgrade
|
Total Liabilities & Equity | 456.5 | 381.34 | 379.82 | 342.65 | 315.34 | 286.26 | Upgrade
|
Total Debt | 3.87 | 11.47 | 0.99 | 0.3 | 5.09 | 14.97 | Upgrade
|
Net Cash (Debt) | 46.28 | 3.64 | 23.92 | 19.67 | 9 | -5.18 | Upgrade
|
Net Cash Growth | 449.63% | -84.77% | 21.59% | 118.67% | - | - | Upgrade
|
Net Cash Per Share | 14.83 | 1.17 | 7.67 | 6.31 | 2.88 | -1.66 | Upgrade
|
Filing Date Shares Outstanding | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | Upgrade
|
Total Common Shares Outstanding | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | Upgrade
|
Working Capital | 277.33 | 218.14 | 236.35 | 215.59 | 183.44 | 142.95 | Upgrade
|
Book Value Per Share | 108.64 | 91.28 | 98.83 | 93.26 | 82.55 | 71.08 | Upgrade
|
Tangible Book Value | 338.96 | 284.78 | 308.35 | 290.98 | 257.56 | 221.78 | Upgrade
|
Tangible Book Value Per Share | 108.64 | 91.28 | 98.83 | 93.26 | 82.55 | 71.08 | Upgrade
|
Land | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | Upgrade
|
Buildings | 14.29 | 14.29 | 14.29 | 12.57 | 12.21 | 11.27 | Upgrade
|
Machinery | 193.82 | 193.79 | 191.74 | 188.76 | 180.06 | 179.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.